{"id":"https://openalex.org/W3030457555","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e20000","title":"A comparison of CD34+ mobilization effects of standard dose pegfilgrastim (Peg) versus low-dose peg combined with plinabulin (Plin).","display_name":"A comparison of CD34+ mobilization effects of standard dose pegfilgrastim (Peg) versus low-dose peg combined with plinabulin (Plin).","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3030457555","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e20000","mag":"3030457555"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.e20000","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e20000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e20000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061736755","display_name":"Douglas W. Blayney","orcid":"https://orcid.org/0000-0002-7931-4533","observed_orcids":["https://orcid.org/0000-0002-7931-4533"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas W. Blayney","raw_affiliation_strings":["Stanford University, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA;","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070754234","display_name":"Lan Huang","orcid":"https://orcid.org/0000-0002-3140-4687","observed_orcids":["https://orcid.org/0000-0002-3140-4687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lan Huang","raw_affiliation_strings":["BeyondSpring Pharmaceuticals, Inc., New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeyondSpring Pharmaceuticals, Inc., New York, NY;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015687794","display_name":"Ramon W. Mohanlal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramon W. Mohanlal","raw_affiliation_strings":["BeyondSpring Pharmaceuticals, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeyondSpring Pharmaceuticals, New York, NY;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"e20000","last_page":"e20000"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.9739999771118164},{"id":"https://openalex.org/keywords/plinabulin","display_name":"plinabulin","score":0.953000009059906},{"id":"https://openalex.org/keywords/cd34-cell-mobilization","display_name":"CD34+ cell mobilization","score":0.9269999861717224},{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6949999928474426},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.6850000023841858},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bone-pain","display_name":"bone pain","score":0.7350000143051147},{"id":"https://openalex.org/keywords/leukocytosis","display_name":"leukocytosis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6759999990463257},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9097850918769836},{"id":"https://openalex.org/C2778658803","wikidata":"https://www.wikidata.org/wiki/Q1592932","display_name":"Pegfilgrastim","level":5,"score":0.6366522908210754},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6042299270629883},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5987207889556885},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.5825137495994568},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4814866781234741},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4185253977775574},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.313851922750473},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3079942464828491},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.e20000","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e20000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e20000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2947292239","https://openalex.org/W2947778483","https://openalex.org/W2978491094","https://openalex.org/W2984749858","https://openalex.org/W3170098415","https://openalex.org/W2961282153","https://openalex.org/W3045540632","https://openalex.org/W2586537389","https://openalex.org/W3171922292","https://openalex.org/W3131553692"],"abstract_inverted_index":{"e20000":[0],"Background:":[1],"Plin":[2,33,72,84,159,221],"is":[3,34,51,104,329],"a":[4,95,166],"novel,":[5],"small":[6],"molecule":[7],"immune-enhancing":[8],"agent":[9,31],"with":[10,116,153,158,220,268,321],"in":[11,16,110,172,292,295,314,333],"vitro":[12],"anticancer":[13],"activity":[14],"currently":[15],"Phase":[17],"(Ph)":[18],"3":[19,108],"clinical":[20,100],"trials":[21],"for":[22,39,306],"NSCLC":[23],"treatment":[24],"and":[25,50,93,127,149,187,213,240,247,263],"Chemotherapy":[26],"(Chemo)-Induced":[27],"Neutropenia":[28],"(CIN).":[29],"Single":[30],"(SA)":[32],"equally":[35],"effective":[36],"as":[37,123],"Peg":[38,102,156,195,309],"the":[40,54,173,296,322],"prevention":[41],"of":[42,57,168,208,259,331],"CIN,":[43],"however":[44],"does":[45],"not":[46,304],"cause":[47],"bone":[48,124,260],"pain":[49],"given":[52],"on":[53],"same":[55],"day":[56],"Chemo":[58,67,280],"by":[59,228],"30":[60,64],"min":[61,65],"IV":[62],"infusion,":[63],"after":[66],"(Blayney":[68,81],"ASH":[69,82],"2018).":[70,143],"SA":[71],"also":[73,192],"mobilizes":[74],"CD34+":[75,146,224,282,301],"cells":[76],"to":[77,88,107],"clinically":[78],"relevant":[79],"levels":[80],"2019).":[83],"has":[85,94],"been":[86],"administered":[87],">":[89],"600":[90],"patients":[91,111],"(pts)":[92,112],"favorable":[96],"safety/tolerability":[97],"profile.":[98],"In":[99,165],"practice,":[101],"dose":[103,118,155,162,202,270,298,308,312,324],"often":[105],"reduced":[106],"mg":[109,217],"experiencing":[113],"side":[114],"effects":[115],"standard":[117],"(6":[119],"mg)":[120],"Peg,":[121],"such":[122],"pain,":[125,261],"myalgia":[126,262],"leucocytosis":[128],"(Kim":[129],"ASCO":[130],"2010;":[131],"Goodman":[132],"Oncology":[133],"Times":[134],"2008;":[135],"Lacovelli":[136],"JHOP":[137],"2012;":[138],"Lower":[139],"Cancer":[140,170],"Chemother":[141],"Pharmacol":[142],"We":[144],"evaluated":[145],"cell":[147,336],"counts":[148,225,283,302],"adverse":[150],"events":[151],"(AE)":[152],"low":[154,201,269,297,311,323],"combined":[157,219],"vs":[160,272,289,310],"full":[161,307],"Peg.":[163,274],"Methods:":[164],"subset":[167],"Breast":[169],"pts":[171,191,215],"CIN":[174],"Ph":[175],"2":[176,214],"trial":[177,254],"BPI-2358-106":[178],"(NCT0329457)":[179],"receiving":[180],"TAC":[181,279],"(taxotere":[182],"(75),":[183],"doxorubicin":[184],"(50":[185],")":[186],"cyclophosphamide":[188],"(500)":[189],"mg/m2,":[190],"received":[193,211],"either":[194],"6mg":[196,273],"(n":[197],"=":[198,206],"7)":[199],"or":[200],"peg":[203],"(":[204],"n":[205],"9,":[207],"which":[209],"7pts":[210],"3mg":[212],"1.5":[216],"Peg)":[218],"(20":[222],"mg/m2).":[223],"were":[226,303,319],"obtained":[227],"central":[229],"laboratory":[230],"FACS":[231],"analysis":[232],"(Covance)":[233],"at":[234],"screening":[235],"(SC),":[236],"Day":[237],"(D)":[238],"6,8":[239],"21":[241],"cycle":[242,293,315],"1":[243,294],"(see":[244],"table":[245],"below)":[246],"AE":[248],"frequency":[249],"was":[250,265],"collected.":[251],"Results:":[252],"Clinical":[253],"information:":[255],"NCT0329457":[256],".":[257],"Frequency":[258],"leukocytosis":[264],"numerically":[266],"lower":[267],"Peg/Plin":[271,299,313,327],"Conclusions:":[275],"Under":[276],"highly":[277],"myelosuppressive":[278],"conditions,":[281],"increased":[284],"significantly":[285],"(p":[286],"<":[287],"0.03)":[288],"predose":[290],"SC":[291],"goup.":[300],"different":[305],"1.":[316],"Adverse":[317],"Events":[318],"fewer":[320],"Peg/Plin.":[325],"The":[326],"combination":[328],"worthy":[330],"test":[332],"hematopoietic":[334],"stem":[335],"mobilization":[337],"regimens.":[338],"[Table:":[339],"see":[340],"text]":[341]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-06-05T00:00:00"}